Liu R, Candela BM, English JC. Nail Psoriasis and Psoriatic Arthritis for the Dermatologist. J Dermatol & Skin Sci. 2020;2(1):17-21 Mini-Review Article Open Access Nail Psoriasis and Psoriatic Arthritis for the Dermatologist Rebecca Liu1, Braden M. Candela2, Joseph C English III2* 1University of Pittsburgh School of Medicine 2Department of Dermatology, University of Pittsburgh, Pittsburgh, PA Article Info Abstract Article Notes Psoriatic arthritis (PsA) may affect up to a third of patients with psoriasis. Received: February 16, 2020 It is characterized by diverse clinical phenotypes and as such, is often Accepted: March 17, 2020 underdiagnosed, leading to disease progression and poor outcomes. Nail *Correspondence: psoriasis (NP) has been identified as a risk factor for PsA, given the anatomical Joseph C. English, MD, PhD, University of Pittsburgh Medical connection between the extensor tendon and nail matrix. Therefore, it Center (UPMC), Department of Dermatology, 9000 Brooktree is important for dermatologists to screen patients exhibiting symptoms Rd, Suite 200, Wexford, PA 15090; Email:
[email protected]. of NP for joint manifestations. On physical exam, physicians should be evaluating for concurrent skin and nail involvement, enthesitis, dactylitis, ©2020 English JC. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License. and spondyloarthropathy. Imaging modalities, including radiographs and ultrasound, may also be helpful in diagnosis of both nail and joint pathology. Keywords: Physicians should refer to Rheumatology when appropriate. Numerous Nail psoriasis systemic therapies are effective at addressing both NP and PsA including Psoriatic arthritis DMARDs, biologics, and small molecule inhibitors. These treatments ultimately Psoriasis can inhibit the progression of inflammatory disease and control symptoms, Treatment Management thereby improving quality of life for patients.